170 related articles for article (PubMed ID: 9746977)
1. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B
Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977
[TBL] [Abstract][Full Text] [Related]
2. Controlling the complement system in inflammation.
Kirschfink M
Immunopharmacology; 1997 Dec; 38(1-2):51-62. PubMed ID: 9476114
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation].
Heckl-Ostreicher B; Kirschfink M
Immun Infekt; 1995 Apr; 23(2):53-4. PubMed ID: 7538095
[TBL] [Abstract][Full Text] [Related]
4. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
5. Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.
Heckl-Ostreicher B; Binder R; Kirschfink M
Clin Exp Immunol; 1995 Dec; 102(3):589-95. PubMed ID: 8536377
[TBL] [Abstract][Full Text] [Related]
6. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion.
McCurry KR; Kooyman DL; Diamond LE; Byrne GW; Logan JS; Platt JL
Transplantation; 1995 Apr; 59(8):1177-82. PubMed ID: 7537395
[TBL] [Abstract][Full Text] [Related]
7. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
[No Abstract] [Full Text] [Related]
8. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives].
Malassagne B; Calmus Y; Houssin D; Weill B
Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil adhesion and complement inhibition prolongs survival of cardiac xenografts in discordant species.
Zehr KJ; Herskowitz A; Lee PC; Kumar P; Gillinov AM; Baumgartner WA
Transplantation; 1994 Mar; 57(6):900-6. PubMed ID: 8154039
[TBL] [Abstract][Full Text] [Related]
10. Protection of porcine endothelial cells from complement-mediated cytotoxicity by the human complement regulators CD59, C1 inhibitor, and soluble complement receptor type 1. Analysis in a pig-to-human in vitro model relevant to hyperacute xenograft rejection.
Heckl-Ostreicher B; Wosnik A; Kirschfink M
Transplantation; 1996 Dec; 62(11):1693-6. PubMed ID: 8970634
[TBL] [Abstract][Full Text] [Related]
11. Sulfonated dextran inhibits complement activation and complement-dependent cytotoxicity in an in vitro model of hyperacute xenograft rejection.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Fischer E; Kazatchkine MD
Mol Immunol; 1996; 33(7-8):643-8. PubMed ID: 8760276
[TBL] [Abstract][Full Text] [Related]
12. Prolongation of discordant renal xenograft survival by depletion of complement. Comparative effects of systemically administered cobra venom factor and soluble complement receptor type 1 in a guinea-pig to rat model.
Chrupcala M; Pomer S; Staehler G; Waldherr R; Kirschfink C
Transpl Int; 1994; 7 Suppl 1():S650-3. PubMed ID: 11271331
[TBL] [Abstract][Full Text] [Related]
13. [Complement in organ xenotransplantation].
Dalmasso AP
Rev Clin Esp; 1996 Mar; 196 Spec No():44-51. PubMed ID: 9206808
[No Abstract] [Full Text] [Related]
14. Pre-treatment of donor with 1-deamino-8-d-arginine vasopressin could alleviate early failure of porcine xenograft in a cobra venom factor treated canine recipient.
Kang HJ; Lee G; Kim JY; Lee SH; Wi HC; Hwang PG; Chung DH; Kim YT
Eur J Cardiothorac Surg; 2005 Jul; 28(1):149-56. PubMed ID: 15982598
[TBL] [Abstract][Full Text] [Related]
15. [Transgenic swine as potential organ donors? Results of the ex-vivo hemoperfusion hDAF transgenic kidney with human blood].
Storck M; Abendroth D; White DJ; Pino-Chavez G; Fakler JA; Hammer C
Zentralbl Chir; 1998; 123(7):785-92. PubMed ID: 9746976
[TBL] [Abstract][Full Text] [Related]
16. Complement activation, its consequences, and blockade by gene transfer.
Carrington CA; Richards AC; van den Bogaerde J; Tucker AW; White DJ
World J Surg; 1997; 21(9):907-12. PubMed ID: 9361503
[TBL] [Abstract][Full Text] [Related]
17. Complement activation and coagulation in xenotransplantation.
Cowan PJ; d'Apice AJ
Immunol Cell Biol; 2009; 87(3):203-8. PubMed ID: 19153592
[TBL] [Abstract][Full Text] [Related]
18. A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantation.
Kroshus TJ; Salerno CT; Yeh CG; Higgins PJ; Bolman RM; Dalmasso AP
Transplantation; 2000 Jun; 69(11):2282-9. PubMed ID: 10868627
[TBL] [Abstract][Full Text] [Related]
19. [Organ xenotransplantation using human complement regulatory factor gene].
Hayashi S; Koike C; Isobe K; Yokoyama I; Takagi H
Nihon Rinsho; 1994 Sep; 52(9):2492-503. PubMed ID: 7967101
[TBL] [Abstract][Full Text] [Related]
20. Targeting complement in therapy.
Kirschfink M
Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
